MAPS developed the first validated method of synthesizing MDMA on an industrial scale while meeting Good Manufacturing Practices. And better yet, they are placing the process in the public domain to promote scientific advances and patient access.
The 4-step process produces up to 5 kg of MDMA (or roughly 30,000 doses) with 99.9% purity.
With MDMA expected to be FDA-approved next year, this advancement comes at the perfect time to meet the growing demand for the drug 👏
Today is MAPS’ 36th birthday 🥳 See all that they’ve accomplished here.
Alistair McTaggart, a University of Queensland researcher, discovered what he believes is a new species of psychedelic mushroom in one of Australia’s biggest national parks.
When interviewed on the finding, he brought attention to an “under-explored” use of psilocybin: animal welfare.
“Psilocybin has use in [treating] anxiety in humans, we don’t understand the effects of psilocybin on animals very well, but I think of slaughterhouses and what this could mean for the meat [processing] industry,” McTaggart explains.
Who knows, maybe we’ll start seeing beef advertised as “shroom-fed” 🤷♀️
A new Johns Hopkins study found that mystical psychedelic experiences are linked to changes in peoples’ beliefs about consciousness.
After a single psychedelic experience, people were much more likely to attribute consciousness to animals, insects, fungi, plants, and even inanimate objects. However, psychedelics had no effect on beliefs about free will or superstition.
What do you think — do mushrooms have consciousness?